News About: Pharm. Industry
Ocostec seeking to develop new RA drug
Oscotec Inc., bone specialized bioengineering company, said that it presented its experimental drug candidate for the treatment of rheumatoid arthritis (RA) in 2011 Annual Scientific meeting of the American College of...
Bae to head Handok Pharmaceutical R&D group
Bae Jin-kun, ex-head of research and development (R&D) in JW Pharmaceutical, was nominated Thursday as new R&D advisor of Handok Pharmaceutical.
Bae, 60, graduated from chemical department at Yonsei University serv...
7 drugmakers seeking to nullify administrative disposition
Claiming nullification on price cuts of 131 drugs, seven Korean drug firms has brought the Ministry of Health and Welfare to the Seoul court. The court will examine the case starting November 11.
The seven companie...
Calls mounting for sale of OTC drugs at supermarkets
The representatives of five economic organizations, including the Federation of Korean Industries (FKI), demanded yesterday the National Assembly pass a bill to revise the Pharmaceutical Affairs Law, designed to allow...
GSK chief wins presidential award
Kim Jin-ho, head of GlaxoSmithKline, received the presidential award from the Ministry of Knowledge Economy at an ceremony for foreign enterprises Thursday, company officials said.
The award gives recognition to e...
Domestic pharmaceutical firms eye price hike of OTC products
Korean drug firms are considering a price hike of their flagship over-the-counter (OTC) drugs as they are by concerned by the potentially significant impact of the government’s new drug pricing reform on the prices an...
Product restructuring daunting task
Influenced by the government’s plan to cut drug prices by an average of 14 percent starting next year, smaller pharmaceutical firms face at times a daunting task of selecting unprofitable products.
However, they ar...
Pharmaceutical firms’ liquidity conditions remain sound
Listed drug firms’ liquidity conditions remained firm in June as companies are set to issue more corporate bonds and increase borrowings as part of efforts to secure capital on worries the ongoing uncertainty will con...
Niels Hessmann to head Bayer Korea
Bayer Korea said Tuesday that it appointed Niels Hessmann as its new president.
Hessmann will replace outgoing Bayer Healthcare CEO Friedrich Gause who served from October 2008.
He served as president of Bayer B...
KPMA vows to defy measures designed to slash drug prices
Asserting that the government’s “ill-conceived” plan to cut drug prices would shake the pharmaceutical industry to its roots, member of the Korea Pharmaceutical Manufacturers Association pledged joint efforts to block...
